Neuroscientists, clinicians and one stubborn question.
Can the blood tell us what is happening inside a neuron? Neurodex was founded in Natick, Massachusetts to answer it — first with a method for isolating neuron-derived vesicles, then with the assays, laboratories and clinical evidence needed to make that answer useful to the people developing therapies for Alzheimer's, Parkinson's and ALS.
Multidisciplinary by design
Scientists, clinicians and technologists share one bench. We work side by side with clinical and research teams so that a biomarker is shaped by the study it will serve, not retrofitted to it.
Concept to clinic
Every result at the bench is developed with an eye on how a physician or trial statistician will use it. Earlier diagnosis, more accurate tracking of progression, better stratification — the measure of success is a clinical decision made sooner.
Integrity as infrastructure
GLP and CLIA compliance, rigorous validation and transparent processes. We will tell you where an assay does not add value — as we do with NF-L — because trust in the results is the product.
Management team
Join the bench.
Open roles in Natick, Massachusetts. We hire people who want to see their assay reach a patient.